Genizon BioSciences is an industry leader in genetic biomarker discovery, with programs in 25 common diseases.

• We discover genes, biomarkers, and biochemical pathways that are involved in disease susceptibility and drug response (pharmacogenomics).



• Our discoveries can assist in the development of novel drug targets and predictive diagnostics that facilitate a personalized medicine approach to treatment.



• We have over 47,000 subjects in our biobank, 95% of which have consented to be re-contacted.



• Our proprietary industrialized biomarker discovery platform is GLP and GCP compliant.

Our Lead Programs

Genizon has completed genome-wide association studies in the following programs:

• ADHD
• Alzheimer's Disease
• Crohn's Disease
• Endometriosis
• Longevity
• Obesity
• Psoriasis
• Rheumatoid Arthritis
• Schizophrenia

Our Services

Genizon also offers rapid, top-quality genetic services at competitive prices:

• SNP Genotyping
• Gene Expression
• DNA Methylation
• Genetic Analysis
• Pharmacogenomics